FTH1 and colorectal cancer: In particular, Y Zheng et al [39] reported that FHC expression inversely correlates with resistance to SN38 (the active metabolite of the topoisomerase inhibitor Irinotecan), as part of a gene signature of drug resistance which would predict patient survival in colorectal cancer.